Next Article in Journal
Identification of Copy Number Aberrations in Breast Cancer Subtypes Using Persistence Topology
Next Article in Special Issue
Mining the Dynamic Genome: A Method for Identifying Multiple Disease Signatures Using Quantitative RNA Expression Analysis of a Single Blood Sample
Previous Article in Journal
Microintaglio Printing for Soft Lithography-Based in Situ Microarrays
Article Menu

Export Article

From the third issue of 2017, Microarrays has changed its name to High-Throughput.

Open AccessArticle
Microarrays 2015, 4(3), 324-338; doi:10.3390/microarrays4030324

Data Mining of Gene Arrays for Biomarkers of Survival in Ovarian Cancer

John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham NG11 8NS, UK
Department of Histopathology, Queens Medical Centre, Derby Road, Nottingham, Nottinghamshire NG7 2NH, UK
Author to whom correspondence should be addressed.
Academic Editor: Stephen J. Walker
Received: 18 June 2015 / Revised: 9 July 2015 / Accepted: 13 July 2015 / Published: 17 July 2015
View Full-Text   |   Download PDF [947 KB, uploaded 22 July 2015]   |  


The expected five-year survival rate from a stage III ovarian cancer diagnosis is a mere 22%; this applies to the 7000 new cases diagnosed yearly in the UK. Stratification of patients with this heterogeneous disease, based on active molecular pathways, would aid a targeted treatment improving the prognosis for many cases. While hundreds of genes have been associated with ovarian cancer, few have yet been verified by peer research for clinical significance. Here, a meta-analysis approach was applied to two carefully selected gene expression microarray datasets. Artificial neural networks, Cox univariate survival analyses and T-tests identified genes whose expression was consistently and significantly associated with patient survival. The rigor of this experimental design increases confidence in the genes found to be of interest. A list of 56 genes were distilled from a potential 37,000 to be significantly related to survival in both datasets with a FDR of 1.39859 × 10−11, the identities of which both verify genes already implicated with this disease and provide novel genes and pathways to pursue. Further investigation and validation of these may lead to clinical insights and have potential to predict a patient’s response to treatment or be used as a novel target for therapy. View Full-Text
Keywords: ovarian cancer; meta-analysis; artificial neural networks; survival analysis; biomarkers; transcriptomics ovarian cancer; meta-analysis; artificial neural networks; survival analysis; biomarkers; transcriptomics

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Coveney, C.; Boocock, D.J.; Rees, R.C.; Deen, S.; Ball, G.R. Data Mining of Gene Arrays for Biomarkers of Survival in Ovarian Cancer. Microarrays 2015, 4, 324-338.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics



[Return to top]
Microarrays EISSN 2076-3905 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top